Lisa Richters

723 total citations
13 papers, 129 citations indexed

About

Lisa Richters is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Lisa Richters has authored 13 papers receiving a total of 129 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 5 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Lisa Richters's work include BRCA gene mutations in cancer (6 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Genomics and Diagnostics (3 papers). Lisa Richters is often cited by papers focused on BRCA gene mutations in cancer (6 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Genomics and Diagnostics (3 papers). Lisa Richters collaborates with scholars based in Germany, Netherlands and Switzerland. Lisa Richters's co-authors include Fabinshy Thangarajah, Peter Mallmann, R Renner, Birgid Markiefka, Klaus Tiemann, Klara Brixius, Wilhelm Bloch, Nicolai Treiber, Stefan Krämer and Karin Scharffetter‐­Kochanek and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Applied Physiology and Clinical & Experimental Metastasis.

In The Last Decade

Lisa Richters

12 papers receiving 126 citations

Peers

Lisa Richters
Lisa Richters
Citations per year, relative to Lisa Richters Lisa Richters (= 1×) peers Emma Titmuss

Countries citing papers authored by Lisa Richters

Since Specialization
Citations

This map shows the geographic impact of Lisa Richters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Richters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Richters more than expected).

Fields of papers citing papers by Lisa Richters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Richters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Richters. The network helps show where Lisa Richters may publish in the future.

Co-authorship network of co-authors of Lisa Richters

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Richters. A scholar is included among the top collaborators of Lisa Richters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Richters. Lisa Richters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Thangarajah, Fabinshy, et al.. (2018). ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases. Clinical & Experimental Metastasis. 35(7). 707–712. 19 indexed citations
3.
Thangarajah, Fabinshy, Wolfram Malter, Stefanie Hamacher, et al.. (2017). A Retrospective Analysis of Ki-67 Index and its Prognostic Significance in Over 800 Primary Breast Cancer Cases. Anticancer Research. 37(4). 1957–1964. 19 indexed citations
4.
Richters, Lisa, Philip C. Schouten, Stefan Kommoss, et al.. (2017). BRCA-like classification in ovarian cancer: Results from the AGO-TR1-trial.. Journal of Clinical Oncology. 35(15_suppl). 5546–5546. 2 indexed citations
5.
Hauke, Jan, André Heimbach, Lisa Richters, et al.. (2016). Next-generation sequencing in BRCA1/2-negative breast and ovarian cancer families.. Journal of Clinical Oncology. 34(15_suppl). 1533–1533. 1 indexed citations
6.
Hahnen, Eric, Klaus Baumann, André Heimbach, et al.. (2016). Prevalence of somatic mutations in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1 study).. Journal of Clinical Oncology. 34(15_suppl). 5544–5544. 5 indexed citations
7.
Kommoss, Stefan, Jan Hauke, Florian Heitz, et al.. (2016). Incidence of germline mutations in risk genes including BRCA1/2 in consecutive ovarian cancer (OC) patients (AGO TR-1). Geburtshilfe und Frauenheilkunde. 76(10). 5 indexed citations
8.
Harter, Philipp, Jan Hauke, Florian Heitz, et al.. (2016). Incidence of germline mutations in risk genes including BRCA1/2 in consecutive ovarian cancer (OC) patients (AGO TR-1).. Journal of Clinical Oncology. 34(15_suppl). 5538–5538. 2 indexed citations
9.
Thangarajah, Fabinshy, F. Bergauer, Katja Engel, et al.. (2015). Cervical screening program and the psychological impact of an abnormal Pap smear: a self-assessment questionnaire study of 590 patients. Archives of Gynecology and Obstetrics. 293(2). 391–398. 25 indexed citations
10.
Malter, Wolfram, Lisa Richters, Birgid Markiefka, et al.. (2014). Intraoperative Boost Radiotherapy during Targeted Oncoplastic Breast Surgery: Overview and Single Center Experiences. International Journal of Breast Cancer. 2014. 1–6. 9 indexed citations
11.
Richters, Lisa, Monika Ortmann, Michael Faust, et al.. (2013). The Oncological Emergency Case: Paraneoplastic Hypoglycemia in Metastatic Breast Cancer - Case Report and Brief Review of the Literature. Breast Care. 8(5). 368–370. 3 indexed citations
12.
Goldstein, Lori J., Célia Tosello Oliveira, Bernhard Heinrich, et al.. (2013). A randomized double-blind phase II study of the combination of oral WX-671 plus capecitabine versus capecitabine monotherapy in first-line HER2-negative metastatic breast cancer (MBC).. Journal of Clinical Oncology. 31(15_suppl). 508–508. 10 indexed citations
13.
Richters, Lisa, Nancy E. Lange, R Renner, et al.. (2011). Exercise-induced adaptations of cardiac redox homeostasis and remodeling in heterozygous SOD2-knockout mice. Journal of Applied Physiology. 111(5). 1431–1440. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026